Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Oral QPX2015 in Healthy Adults
NCT03939429Phase 1Completed
- Sponsor
- Qpex Biopharma
- Start
- May 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bacterial infection comparing QPX2015 with Placebo (2 arms). Primary endpoints: Incidence of Treatment-Emergent Adverse Events, Changes from baseline in safety parameters and 5 more. Started May 2019; status: completed.
02
Drugs
ceftibuten
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03939429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03939429.